Table 1.
Demographic and clinical characteristics of the 230 patients enrolled.
| Patient Characteristics | Values |
|---|---|
| Age, years, median [IQR] | 57 [44–66] |
| Female, n (%) | 149 (65) |
| ≤ High school education, n (%) | 164 (71) |
| Medicaid, n (%) | 161 (70) |
| Born outside of the US, n (%) | 220 (96) |
| Marin and Marin acculturation score, median [IQR] | 15 [14–22] |
| Rheumatologic diagnosis, n (%) | |
| Rheumatoid arthritis | 95 (41) |
| Systemic Lupus Erythematosus | 40 (17) |
| Spondyloarthropathies | 34 (15) |
| Sjogrens syndrome | 27 (12) |
| Gout/Pseudogout | 13 (6) |
| Other* | 21 (9) |
| Disease duration, years, median [IQR] | 4 [2–8] |
| Rheumatic medications, n (%) | |
| Disease modifying anti-rheumatic drugs (DMARDs)§ | 191 (83) |
| Biologics or small molecule† | 60 (26) |
| Steroids | 62 (27) |
IQR = interquartile range; SD = standard deviation;
*
Other diagnoses included myositis (5), systemic sclerosis (3), undifferentiated connective tissue disease (3), inflammatory osteoarthritis (2), palindromic rheumatism (2), juvenile idiopathic arthritis (2), polymyalgia rheumatic (1), relapsing polychondritis (1), iritis (1), panniculitis (1);